Expanding Pharmaceutical Access Via Over the Counter Drugs
Therapeutic Innovation & Regulatory Science · 2025
DOI: 10.1007/s43441-024-00709-3 ↗Kurz gefasst
Leserbrief in der Zeitschrift Therapeutic Innovation & Regulatory Science, 2025. Verfasst von Terra Marie M Jouaneh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA. Hauptthemen laut MEDLINE: Nonprescription Drugs, United States Food and Drug Administration. Die Arbeit nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
This commentary addresses the recent U.S. Food & Drug Administration (FDA) proposed rule to expand access to nonprescription drugs through additional conditions of nonprescription use (ACNU). It surveys the various pathways to market for pharmaceutical products, noting the distinct requirements for over-the-counter (OTC) products differentiating them from prescription products. It subsequently reviews the ACNU proposed rule, weighing its potential benefits against possible limitations. With a view towards the future, the ACNU proposed rule is acknowledged as part of a longstanding tradition to expand drug channels in a risk-stratified fashion with increasing clinical oversight to address in tandem increasing consumer risks. Finally, the proposed rule also serves as a potential prelude for a future behind the counter drug pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA.
- Massachusetts General Hospital, Boston, MA, 02114, USA.
- Harvard Medical School, Boston, MA, 02115, USA.
- Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, 21287, USA. brian@brianjmillermd.com.
- American Enterprise Institute, Washington, DC, 20036, USA. brian@brianjmillermd.com.
Zitieren
APA
Jouaneh, T. M. M., Gowda, V., & Miller, B. J. (2025). Expanding Pharmaceutical Access Via Over the Counter Drugs. Therapeutic Innovation & Regulatory Science. https://doi.org/10.1007/s43441-024-00709-3
Vancouver
Jouaneh TMM, Gowda V, Miller BJ. Expanding Pharmaceutical Access Via Over the Counter Drugs. Therapeutic Innovation & Regulatory Science. 2025. doi:10.1007/s43441-024-00709-3
BibTeX
@article{Jouaneh2025,
author = {Jouaneh, Terra Marie M and Gowda, Vrushab and Miller, Brian J},
title = {Expanding Pharmaceutical Access Via Over the Counter Drugs},
journal = {Therapeutic Innovation & Regulatory Science},
year = {2025},
doi = {10.1007/s43441-024-00709-3}
}
EUVIMED